Analysis And Comparison Of Competitive Ability Between Multinational Pharmaceutical Companies And Chinese Pharmaceutical Companies

In the background of global economic integration, the domestic market combined with the global market. Since the 80s of the 20th century, top 20 multinational pharmaceutical companies in the world invested in China, establishing more and more research and development centers. Multinational pharmaceutical companies attached great importance to Chinese market, and Chinese market share expanded continuously. Chinese market has been multinational pharmaceutical companies'major profit sources. In the more and more intense competition among pharmaceutical enterprises, Chinese pharmaceutical companies will meet more challenges.How to increase their core competitive ability is an important task.The development of multinational pharmaceutical companies is noticeable. One, they valued the development of Chinese economy and the stability of Chinese social environment, which domestic pharmaceutical companies have to be added to the keep competition. The other, their medicines made leading position in domestic large hospitals and acquired competitive advantages in appeal talents and so on. With the development of the theory of enterprise competition, especially about enterprise's core competition, the comparing of competitive ability between multinational pharmaceutical companies and Chinese pharmaceutical companies is our major aim.We wish that this summary can play a role in the future development of domestic pharmaceutical enterprises and government decision-making.Chapter 1 introduces basic condition, development and competitive stratagem of multinational pharmaceutical companies and Chinese pharmaceutical companiesChapter 2 introduces the theory of enterprise's competition, especially on elements of competition construction, which is the basis of the text.Chapter 3 analyzes product competition, capital competition, research and development competition, pharmaceutical technology competition, marketing competition, human resource competition and enterprise culture competition between multinational pharmaceutical companies and Chinese pharmaceutical companies, using quantitative research and case research methods.Chapter 4 discusses and summarizes the results of chapter 3, and provides some suggestions and countermeasures from enterprise and government angle, to wish best development of Chinese pharmaceutical companies in global market.